Table 1 Demographics and clinical characteristics of CD patients and healthy controls (HC).

Gender; male/female

6/9

6/8

1

Age, years; mean (SD)

41.3 (3.5)

42 (13)

0.842^*

Education, years; mean (SD)

14.7 (0.7)

15 (2.7)

0.681^*

BMI; mean (SD)

27.1 (4.9)

26.3 (3)

0.8^*

Cardiovascular risk factors; n

9

8

1^†

smokers; n

7

7

1

packyears; mean (SD)

13.6 (9)

15.3 (12.5)

0.774^*

hypertension; n

4

3

1^†

BDI; mean (SD)

7.5 (4.8)

4.9 (5)

0.107^‡

HADS-A; mean (SD)

5.9 (3.9)

4.6 (2.7)

0.407^‡

WEIMuS; mean (SD)

16.7 (12.5)

11.9 (15.7)

0.162^‡

MoCA; mean (SD)

28.1 (1.4)

27.9 (2.3)

1^‡

CDAI; mean (SD)

33 (38)

—

—

Disease duration, years; mean (SD)

18.1 (13.9)

—

—

Fecal Calprotectin, g/kg; mean (SD)

40.5 (42.2)

—

—